The Yvonne Award, symbolizing the strength and longevity of the yew tree, honors exceptional achievements in oncology with its unique Y-shaped sculpture that embodies resilience. Designed to recognize young innovators and leaders advancing cancer care, this award celebrates excellence and innovation in the field.
Yvonne Award will be given during the OncoDaily Party 2026 on May 29th.
Eligibility and Nomination Requirements
-
- Candidates must be within 15 years post-faculty appointment or after receiving their terminal degree.
- Both trainees and seasoned professionals are eligible to be nominated.
- It is mandatory for the awardee to attend the ASCO Annual Meeting and Yvonne Award Ceremony on May 29th in person
- Nominations should include a CV (limited to 2 pages)
- Self-nominations are not accepted
Only nominations that fully satisfy the eligibility requirements will be reviewed; ineligible applications will not be considered.
Yvonne Award Categories
-
- Breakthrough Research
- Global Oncology
- Community Oncology
- Leadership
- Mentorship
- Challenging the Status Quo
- Pediatric Oncology
- Humanitarian Award
- AI in Oncology∗
∗AI in Oncology award is given by ZS.
Please submit your nominations for the Yvonne Award through the following link.
The deadline for the nominations is April 1, 2026.
Yvonne Award Nomination Committee
2026 Co-chairs
Miriam Mutebi (Kenya) is a breast surgical oncologist, assistant Professor of Surgery at Aga Khan University Hospital, Nairobi. She is the Past-President of the African Organization for Research and Training in Cancer (AORTIC), Past-President of the Kenya Society of Hematology and Oncology (KESHO), and Board Member of the Union for International Cancer Control (UICC). She is also a co-founder of the Pan African Women’s Association of Surgeons (PAWAS)
Philip Kantoff (USA) – CEO and Co-Founder, Convergent Therapeutics, Past Chairman of Medicine at Memorial Sloan Kettering Cancer Center, Jerome and Nancy Kohlberg Emeritus Chair in Medicine at Harvard Medical School
Members
Lynn Schuchter (USA): – Co-chair of Yvonne Award 2025: ASCO Board Chair and Past-President, Chief of the Division of Hematology-Oncology at the Abramson Cancer Center at the University of Pennsylvania and the Director of the Tara Miller Melanoma Center, Professor of Clinical Oncology, the Madlyn and Leonard Abramson. 2019 the Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award Recipient
Larry Norton (USA): – Co-chair of Yvonne Award 2025 ASCO Past-President, Senior Vice President of the Memorial Sloan Kettering Cancer Center, Medical Director of the Evelyn H. Lauder Breast Center, Norna S. Sarofim Chair in Clinical Oncology, Professor of Medicine, Weill-Cornell Medical College, Founder and Scientific Director of the Breast Cancer Research Foundation, 2004 ASCO David Karnofsky Memorial Award Recipient.
Lillian Siu (Canada) – Co-chair of Yvonne Award 2024: President-Elect of the American Association for Cancer Research (AACR), Director of the Phase I Clinical Trials Program and Co-Director of the Bras and Family Drug Development Program, Clinical Lead for the Tumor Immunotherapy Program, BMO Chair in Precision Genomics at the Princess Margaret Cancer Centre, Professor of Medicine at the University of Toronto, 2024 ASCO David Karnofsky Memorial Award Recipient
Giuseppe Curigliano (Italy) – Co-chair of Yvonne Award 2024: President-Elect of European Society of Medical Oncology (ESMO). Professor of Medical Oncology at the University of Milano, Chief of the Clinical Division of Early Drug Development at European Institute of Oncology, Chair of the ESMO Clinical Practice Guidelines Committee, Member of the Italian Higher Health Council
Abdul Rafeh Naqash (USA) – Medical oncologist and an Assistant Professor at the University of Oklahoma College of Medicine and is the Director of Immuno-Oncology at the Stephenson Cancer Center’s TSET Phase I Program, Yvonne Award 2025 recipient
Abeid Mohamed Athman Omar (Kenya) – Head of Oncology Department at Kenyatta University Teaching, Referral and Research Hospital, Yvonne Award 2024 recipient
Abiola Ibraheem (USA) – Assistant Professor of Clinical Medicine, Department of Medicine, Division of Hematology/Oncology
Adeseye Michael Akinsete (Nigeria) – Associate Professor of College of Medicine at the University of Lagos, Director of Lagos Paediatric Oncology Registry, Honorary Pediatric Hematologist and Oncologist, Lagos University Teaching Hospital, Idi-Araba
Adriana Albini (Italy) – Co-Editor-in-Chief of CancerWorld Magazine, scientific collaborator at the European Institute of Oncology in Milan, and a Professor of General Pathology at Milan Bicocca University
Afsaneh Barzi (USA) – BeiGene Senior Director of Medical Affairs, GI Disease Lead
Ajay Aggarwal (UK) – Consultant Clinical Oncologist at Guy’s and St Thomas’ NHS Trust and Honorary Senior Lecturer at King’s College London in the Department of Cancer Epidemiology
Alberto Costa (Italy) – CEO of the European School of Oncology
Aleksandra Filipovic (UK) – Head of Oncology at PureTech Health, Scientific Clinical Adviser at SPCC
Alexandru Eniu (Switzerland) – Chairman of the European School of Oncology (ESO) College, Consultant Medical Oncologist at the Genolier Cancer Center, Clinique de Genolier
Alicia Zhou (USA) – Chief Executive Officer of the Cancer Research Institute, recognized as one of the 100 Most Influential CEOs in Oncology in 2025
Alique Topalian (USA) – Research Scientist of Survivorship and Supportive Services at the University of Cincinnati Cancer Center
Allison O’Neill (USA) – Clinical Director of Solid Tumor Program, Pediatric Hematology/Oncology, Dana-Farber Cancer Institute, Associate Professor, Harvard University, Vice President, Clinical Performance Management, Dana-Farber Cancer Institute
Amy Israel (Switzerland) – Senior Advisor, Access to Medicines at Union for International Cancer Control (UICC)
Amy Moore (USA) – Director of Patient Engagement and Advocacy, Summit Therapeutics; Former Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation
Andre Ilbawi (Switzerland) – Technical lead, Cancer Control Department of Noncommunicable Diseases, Rehabilitation and Disability (NCD), World Health Organization
Andrea Bullock (Israel) – Assistant Professor at the Medicine Division of Medical Oncology, Beth Israel Deaconess Medical Center
Andreas Charalambous (Cyprus) – Chair, Department of Nursing at Cyprus University of Technology
Andrew Spiegel (USA) – is co-founder and executive director of the Global Colon Cancer Association (GCCA), co-founder of the Colorectal Cancer Alliance (formerly Colon Cancer Alliance), recognized among the 100 Most Influential CEOs in Oncology in 2025
Angela Shakespeare (USA) – Senior Director, Thought Leader Engagement and Strategic Partnerships at AVEO Oncology
Anna Spreafico (Canada) – Yvonne Award 2024 Recipient, Associate Professor at the University of Toronto, Medical Oncologist and Clinician-Investigator in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre
Aparna Parikh (USA) – Harvard Medical School, Program Director, GI Medical Oncology, Director of the Global Cancer Care Program, MGB Cancer Institute, Chief Scientist and Co-Founder, Reversing Early Recurrence
Armen Avagyan (Armenia) – Medical Oncologist, Department of Oncology at Mikaelyan Institute of Surgery, Assistant Professor of Oncology at Yerevan State Medical University, Past-President of the Armenian Association of Hematology and Oncology
Asem Mansour (Jordan) – Director General of King Hussein Cancer Center, recognized among the 100 Most Influential CEOs in Oncology in 2025
Asya Agulnik (USA) – Yvonne Award 2024 Recipient, Director of Global Critical Care Program and EURO Regional Program at St. Jude Global, St. Jude Children’s Research Hospital
Bahar Laderian (USA) – Assistant Professor of Medicine and Oncology at the Albert Einstein College of Medicineand the Director of the Neuroendocrine Tumors Program at the Montefiore Einstein Comprehensive Cancer Center, New York
Barbara Ewals (Switzerland) – CEO of the International Society of Geriatric Oncology, recognized as one of the 100 Most Influential CEOs in Oncology in 2025
Bernard Fox (USA) – Scientific Director of the Harder Family Chair for Cancer Research, Member and Chief, Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, a division of Providence Cancer Institute
Bishal Gyawali (Canada) – Medical oncologist and associate professor in medical oncology and public health sciences, Queen’s University, Kingston, Co-leader of the Common Sense Oncology movement
Carlos Rodriguez-Galindo (USA) – Executive Vice President and Chair of the Department of Global Pediatric Medicine, Director of St. Jude Global, Co-Associate Director, Outreach, Comprehensive Cancer Center, Four Stars of Chicago Endowed Chair in International Pediatric Outreach, recognized as one of the 100 Most Influential People in Oncology in 2025
Catharine Young (USA) – Former Assistant Director for Policy and International Engagement for the Biden Cancer Moonshot at the White House Office of Science and Technology Policy, Yvonne Award 2025 recipient
Cathy Eng (USA) – David H. Johnson Endowed Chair in Surgical and Medical Oncology, Professor of Medicine, Hematology and Oncology,
Director for Strategic Relations, Co-Director of GI Oncology and Co-Leader, GI Cancer Research Program, Director of Young Adult Cancers Program, Vanderbilt-Ingram Cancer Center, Vice-Chair for the SWOG GI Committee
Christine Parseghian (USA) – Associate Professor of Gastrointestinal Medical Oncology at MD Anderson Cancer Center
Daiming Fan (China) – President of China Anti-Cancer Association (CACA), President of World Association for Integrative Oncology (WAIO), President of Asian Oncology Society (AOS), Vice President of Chinese Academy of Engineering, Past President of Fourth Military Medical University, Past President of Chinese Society of Gastroenterology, Director of Xijing Hospital of Digestive Diseases, Director of State Key Laboratory of Cancer Biology
Darien Laird (Switzerland) – Executive Director of the Global Coalition for Radiotherapy
Dario Trapani (Italy) – Medical oncologist at the European Institute of Oncology (IEO) in Milan and an Assistant Professor in the Department of Oncology and Hemato-Oncology at the University of Milan, Yvonne Award 2025 recipient
Darya Kizub (USA) – Assistant Professor in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, Yvonne Award 2025 recipient
David Kerr (UK) – Professor of Cancer Medicine, University of Oxford, Honorary Consultant Medical Oncologist, Oxford Cancer Centre, Co-Director, Oxford-Sichuan Gastrointestinal Cancer Centre, Honorary Professor of Oncology, Sichuan University, Honorary Professor of Oncology, University of Oslo
Davit Zohrabyan (Armenia) – Head of the Adult Solid Tumours and Chemotherapy Clinic at Yeolyan Oncology and Hematology Center, ESMO National Representative in Armenia
Deanna B. van Gestel (USA) – Founder and Chief Executive Officer of Vaniam Group, recognized as one of the 100 Most Influential People in Oncology in 2025
Dhan Chand (USA) – Vice President of Research, Agenus Inc.
Diana Romero (UK) – Chief Editor at Nature Research (Publishing)\
Dilyara Kaidarova (Kazakhstan) – Chairman of the Board at the Kazakh Institute Of Oncology and Radiology, President of the Kazakhstan Cancer Society
Dinesh Pendharkar (India) – Director of Oncology, Sarvodaya Hospital, Faridabad, Chairman of the National Cancer Society, Past-President of the Indian Society of Oncology, Past-President of the Indian Society of Medical and Paediatric Oncology (ISMPO), Past Chair of the ASCO International Committee
Donjeta Bali (Albania) – Head of Pediatric OncoHematology Service, “Mother Teresa” University Hospital Center at Department of Pediatrics, Faculty of Medicine, University of Medicine, Tirana
Douglas Flora (USA) – Editor in Chief of AI in Precision Oncology, President-Elect of Association of Cancer Care Centers (ACCC), Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, Vice-Chair of the American Cancer Society Regional Board
Dragana Stanic Tisma (Qatar) – Consultant Radiation Oncologist, NCCCR, Hamad Medical Corporation, Doha, Qatar
Eduardo Cazap (Argentina) – Argentinean medical oncologist, Founder and first president of the Latin American, Caribbean Society of Medical Oncology (SLACOM), Past- President of the International Union against Cancer (UICC), and Emeritus Professor, Latin-American School of Oncology
Emad Shash (Egypt) – Medical Director & General Manager, Breast Comprehensive Cancer Hospital at the National Cancer Institute, Cairo University
Eric Bouffet (Canada) – Past-President of the International Society of Pediatric Oncology (SIOP), UICC Board Member
Eric Van Cutsem (Germany) – Medical Doctor, Professor of Medicine, Head of Digestive Oncology at University Hospital Gasthuisberg
Erica Barnell (USA) – Co-Founder and Chief Medical and Science Officer Geneoscopy
Erica Tsang (Canada) – Medical oncologist at the Princess Margaret Cancer Centre and an Assistant Professor at the University of Toronto, Yvonne Award 2024 recipient
Erika Hamilton (USA) – Chair of the Executive Committee, Breast and Breast Program Lead at Sarah Cannon Research Institute
Erika Ruiz-Garcia (Mexico) – Director of Teaching at the National Cancer Institute, Mexico, Education Program Chair-Elect 2025-2026 at ASCO
Fabio Ynoe de Moraes (Toronto) – Associate Professor at Queen’s University, Department of Oncology
Fadlo Khuri (Lebanon) – President of the American University of Beirut
Fatima Cardoso (Portugal) – Breast oncologist, President of the Advanced Breast Cancer (ABC) Global Alliance, Yvonne Award 2025 recipient
Felipe Roitberg (Brazil) – Medical Oncologist, Research, Innovation, and Health Technology Assessment Coordinator – Brazilian University Hospitals Network – Rede Ebserh
Florian Scotté (France) – Head of the interdisciplinary department for patient pathway organisation (DIOPP) at Gustave Roussy, Associate Professor of Medical Oncology at the University of Paris-Saclay, MASCC President
Foluke Sarimiye (Nigeria) – Community Oncologist at University of Ibadan, Yvonne Award 2024 recipient
Gabrielle van Ramshorst (Belgium) – Professor of Gastrointestinal Surgical Oncology, Ghent University Hospital
Garik Sagoyan (Russia) – Pediatric Oncologist and Senior Researcher at the N.N. Blokhin National Medical Research Center of Oncology in Moscow, Yvonne Award 2025 Recipient
George Kapetanakis (Greece) – President of the Hellenic Cancer Federation – ELLOK
Ghassan Abou-Alfa (USA) – Professor of Medicine at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Immediate Past-Chair of the National Cancer Institute (NCI) Hepatobiliary Task Force
Gilberto Lopes (USA) – Chief of the Medical Oncology Division, Sylvester Comprehensive Cancer Center, Board Member, Union for International Cancer Control (UICC), Chair, ATOM Coalition, Editor-in-Chief emeritus, JCO Global Oncology
Greg Kalemkerian (USA) – Professor of Internal Medicine at the University of Michigan, Associate Division Chief for Faculty Development & Education, and Associate Director of the Hem/Onc Fellowship Program, Medical School, Chair of the NCCN Small Cell Lung Cancer Guideline Panel
Hadi Mohamad Abu Rasheed (Qatar) – Scientific Advisor, Head of the Professional Development and Scientific Research Department, Qatar Cancer Society
Harout Semerjian (USA) – President and CEO of Geron Corporation
Herdee Gloriane C. Luna (Philippines) – Medical Oncologist at the National Kidney and Transplant Institute, Philippines
Hesham Elghazaly (Egypt) – Elected President of the Executive Board at Egyptian Cancer Society, Professor of Clinical Oncology at Ain Shams University, and the Founder and CEO of Alfa Cure Oncology Center
Hiba Al-Tarrah (Saudi Arabia), Director of Quality Improvement, Consultant Pediatric Hematologist/Oncologist, and Pediatric Hematology/Oncology Fellowship Program Director at King Fahad Specialist Hospital, Dammam
Holli Kolkey (USA) – Vice President of Corporate Affairs/Communications at Arcus Biosciences
Ilaria Colombo (Switzerland) – Medical Oncologist at Oncology Institute of Southern Switzerland
Ilya Tsimafeyeu (Russia) – Director, Bureau for Cancer Research, ASCO Central and Eastern Europe Regional Council Member
Isabel Mestres (Switzerland) – CEO of the City Cancer Challenge (C/Can)
Ishwaria Subbiah (USA) – Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research Institute (SCRI)
Iskra Daskalova (Russia) – Consultant Breast Surgeon at European Medical Centre in Moscow
Jackson Orem (Uganda) – Executive Director, Uganda Cancer Institute,
Jasmine Kamboj (USA) – Community Oncologist and Hematologist at Mayo Clinic, Co-Lead of the ASCO Policy Communities of Practice, Minnesota Society of Clinical Oncology Board Member, OncoDaily Host and Editor of “Empowering Oncologists” Podcast
Jean-Yves Blay (France) – Professor of Medicine at the University Claude Bernard in Lyon, General Director of the Centre Leon Berard, the Comprehensive Cancer Centre of Lyon, President of the French Federation of Comprehensive Cancer Centers
Jenny Seligmann (UK) – Consultant Medical Oncologist at Leeds Teaching Hospitals NHS Trust and Professor of Gastrointestinal Oncology at the University of Leeds
Joseph Grossman (USA) – Vice President of Early Clinical Development, Agenus
Joshua Brody (USA) – Associate Professor, Division of Hematology and Oncology at Icahn School of Medicine, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute, Mount Sinai
Joyson Karakunnel (USA) – Senior Vice-President, Head of Research, Oncology at GSK, Independent Board Member
Judy Habib (USA) – Board Chair of St. Jude Children’s Research Hospital, past Chair of ALSAC, past President of the International Women’s Forum of Massachusetts, and Founding visionary of KHJ Brand Activation
Julie Torode (UK) – Director of Strategic Partnerships, Patient and Community Engagement, Institute of Cancer Policy at King’s College London
Justin Stebbing (UK) – Editor-in-Chief of Oncogene, Visiting Professor of Cancer Medicine and Oncology, Imperial College of London, Professor of Biomedical Sciences, ARU, Cambridge
Karen Canfell (Australia) – AC FAHMS Professor of Public Health and NHMRC Leadership Fellow Lead – Cancer Elimination Collaboration, Sydney School of Public Health, The University of Sydney Lead – Elimination Partnership in the Indo-Pacific for Cervical Cancer (EPICC)
Karen Knudsen (USA) – CEO of the Parker Institute for Cancer Immunology, Professor (Emerita)- Sidney Kimmel Comprehensive Cancer Center at Jefferson Health and Thomas Jefferson University
Karen McLean (USA) – Professor of Oncology, Gynecologic Oncology, Roswell Park Comprehensive Cancer Center
Katherine Van Loon (USA) – Director of the Global Cancer Program at the UCSF Helen Diller Family Comprehensive Cancer Center, Editor-in-Chief of JCO Global Oncology (JCO GO)
Kathleen M. Schmeler (USA) – Professor in the Department of Gynecologic Oncology and Reproductive Medicine, Associate Vice President of Global Oncology, Division of Cancer Network, The University of Texas MD Anderson Cancer Center
Khaled Ghanem (Syria) – Medical Director, BASMA Pediatrics Oncology Unit, Damascus
Lacy Hubbard (USA) – President and Chief Executive Officer of Elekta Foundation
Layth Mula-Hussain (Canada) – Radiation Oncologist at the BC Cancer Centre for the North, Clinical Assistant Professor of the University of British Columbia, Vancouver, BC, Canada
Leo Mascarenhas (USA) – Director of the Sarcoma Program and Division Chief and Director at Cedars-Sinai
Leslie Lehmann (USA) – Director of Clinical Stem Cell Transplantation Program, Medical Director for International Hematology/Oncology/BMT at Boston Children’s Hospital
Liana Safaryan (Armenia) – Chief of the Department of Oncology, Yeolyan Hematology and Oncology Center
Lidia Schapira (USA) – Co-Editor-in-Chief of the CancerWorld Magazine, Professor of Medicine, Stanford University School of Medicine, Director of the Cancer Survivorship Program, Faculty Co-Director for Clinical Research and Clinical Trials, Office of Cancer Health Equity at Stanford Cancer Institute, Associate Editor of the Journal of Clinical Oncology
Lilit Harutyunyan (Armenia) – Head of Oncology Clinic at Mikaelyan Institute of Surgery, Chairperson of the Department of Oncology at Yerevan State Medical University
Loizos Loizou (Cyprus) – Head of Cyprus International Action Plan for Children with Cancer at ELPIDA Foundation for Children with Cancer, Professor at the Medical School of the University of Nicosia
Lorelei Mucci (USA) – Head of the Cancer Epidemiology and Cancer Prevention Program, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Director of Strategic Research Partnerships at the American Cancer Society
Lucia Masarova (USA) – Assistant Professor in the Department of Leukemia, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, Houston
Manette Le Grange (France) – Corporate Social Responsibility Lead, Servier’s ICONIC Initiative
Marta Salek (USA) – Pediatric palliative oncologist at St. Jude Children’s Research Hospital, instructor in the Department of Global Pediatric Medicine at St. Jude.
Martha Raymond (USA) – Founder and CEO of the GI Cancers Alliance, Inc., Founder and CEO, The Raymond Foundation, Inc., Advisor / Board of Directors, Man Up To Cancer, Inc.
Mary Gospodarowicz (Canada) – Professor of Radiation Oncology at the University of Toronto, Princess Margaret Cancer Centre
Maryam Lustberg (USA) – Immediate Past-President of the Multinational Association of Supportive Care in Cancer (MASCC), Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, Chief of Breast Medical Oncology, Associate Professor of Internal Medicine (Medical Oncology) at Yale
Marzia Zambon (Italy) – Executive Director EUROPA DONNA, The European Breast Cancer Coalition
Matti Aapro (Switzerland) – President of Sharing Progress in Cancer Care (SPCC), President of All.Can, Past-President of European Cancer Organization (ECO), Chair of the Editorial Board of OncoDaily Medical Journal, Board Member of UICC
Melvin LK Chua (USA) – Head of the Department of Head Neck and Thoracic Cancers, Division of Radiation Oncology at National Cancer Centre Singapore
Mina Sedrak (USA) – Associate Professor of Medicine and Director of the Cancer and Aging Program at the David Geffen School of Medicine at UCLA
Monica Malik (India) – Professor and Head of the Department of Radiation Oncology, Nizam’s Institute of Medical Sciences
Myriam Chalabi (Netherlands) – Medical Oncologist and Cancer Immunotherapy researcher, Gastrointestinal Oncology at Antoni van Leeuwenhoek
Nagashree Seetharamu (USA) – Professor at Zucker School of Medicine at Hofstra/Northwell, Director of Thoracic and Head/Neck Malignancies at Northwell Health
Nazik Hammad (Canada) – Professor in the Division of Hematology-Oncology at St. Michael’s Hospital, University of Toronto, Chair of the Education and Training Committee of the African Organization in Research and Training in Cancer (AORTIC), Executive Member of the Global Oncology Program at Queen’s University
Nelya Kovalchuk (USA) – Assistant Professor at Harvard Medical School and founder of the Global Medical Knowledge Alliance, Colorectal Surgeon at the Brigham and Women’s Hospital
Nermean Mostafa (Egypt) – Consultant of Clinical Oncology at Gustave Roussy International, Egypt, Lecturer of Clinical Oncology at ASU, Head of the Awareness committee of the Presidential initiative of Cancer early detection and management in Egypt
Nicholas DeVito (USA) – Assistant Professor of Medicine at the Division of Medical Oncology at Duke University
Nicholas Sarlis (USA) – Chief Medical Officer at CLEARA Biotech BV
Nirmala Bhoo-Pathy (Malaysia) – Professor of (Clinical) Epidemiology, Faculty of Medicine, University Malaya, Public Health Medicine Specialist, University Malaya Medical Centre
Oliver Bogler (USA) – CEO of the Night Science Institute
Olubukola Ayodele (UK) – Consultant Medical Oncologist and Breast Cancer Tumour Lead, University Hospitals of Leicester NHS Trust, Honorary Senior Lecturer, Leicester Cancer Research Centre, University of Leicester
Onyinye Balogun (USA) – Assistant Professor of Radiation Oncology at Weill Cornell Medicine, Co-Founder/CMO Mission-Driven Tech
Paolo Tarantino (USA) – Clinical Research Fellow at Dana-Farber Cancer Institute, Yvonne Award 2025 recipient
Peggy Ann Torney (USA) – Chief Executive Officer of MDS Foundation
Petros Grivas (USA) – Professor and Clinical Director of Genitourinary Cancers Program at University of Washington, Department of Medicine, Division of Hematology Oncology, and at Clinical Research Division, Fred Hutch Cancer Center
Philip Philip (USA) – Director of the Gastrointestinal Oncology, Co-Director of the Pancreatic Cancer Center, and Medical Director of the Research and Clinical Care Integration at the Henry Ford Cancer Institute.
Piotr Wysocki (Poland) – Professor and the Head of the Clinical Oncology Department at Jagiellonian University-Medical College, Past-President of the Polish Society of Clinical Oncology, Chair of the ASCO European Regional Council
Pramesh CS (India) – Director of the Tata Memorial Hospital and the Professor and Head of Thoracic Surgery at the Tata Memorial Centre, Board Member of Union for International Cancer Control (UICC), Convener for the National Cancer Grid of India
Rachel Riechelmann (USA) – Director of Clinical Oncology, Head of Oncology, and Head of Neuroendocrine Tumors Reference Center at A.C.Camargo Cancer Center
Rachna Shroff (USA) – Chief of the Division of Hematology/Oncology at UA COM-T, Associate Director of Clinical Investigations, Professor of Medicine, University of Arizona Cancer Center
Rami Komrokji (USA) – Vice Chair of the Malignant Hematology Department at Moffitt Cancer Center
Rawad Rihani (Jordan) – Associate Member, the Deputy Chairman in the Department of Pediatrics, a Consultant in the Department of Pediatric Hematology/Oncology, and a Consultant in the Department of Bone Marrow and Stem Cell Transplantation at the King Hussein Cancer Center in Amman, Liaison for the King Hussein Cancer Center-St. Jude Children’s Research Hospital collaboration
Rob Pieters (Netherlands) – President of the International Society of Pediatric Oncology (SIOP), Chief Máxima International at the Princess Máxima Center
Robert A. Winn (USA) – Director and Lipman Chair in Oncology, VCU Massey Comprehensive Cancer Center, Professor of pulmonary disease and critical care medicine, VCU School of Medicine
Robert Peter Gale (USA) – Emmy award-winning hematologist, Editor-in-Chief of Leukemia
Robin Jones (UK) – Head of the Sarcoma Unit at The Royal Marsden NHS Foundation Trust
Robin Zon (USA) – Chair of ASCO Society 2025-2026, Former President of ASCO, Past President of Michiana Hematology Oncology, Current Director of Breast Oncology, Cincinnati Cancer Advisors
Ruben Mesa (USA) – President of Cancer National Service Line at Advocate Health, and President of Atrium Health Levine Cancer
Runcie Chidebe (Nigeria) – Executive Director, Project PINK BLUE Health and Psychological Trust Centre (HPTC)
Samvel Danelyan (Armenia) – Honorary President of the Armenian Association of Hematology and Oncology, Former Director of the Yeolyan Hematology and Oncology Center, Senior Adviser at the Immune Oncology Research Institute
Sana Al-Sukhun (Jordan) – Director of Al Hyatt Oncology Practice, Chair of the MBC RSG Committee of ASCO, Past Chair of the International Affairs Committee of ASCO, Past President of the Jordanian Oncology Society, Adjunct Professor of Medical Oncology
Sandra D’Angelo (USA) – Associate Attending Physician, sarcoma medical oncologist at Memorial Sloan Kettering Cancer Center
Sara Lonardi (Italy) – Chief of the Oncology 3 Unit and Chief of Phase I Clinical Trial Unit of Veneto Institute of Oncology (IOV) – IRCCS
Sara Tolaney (USA) – Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School
Sarah Tasian (USA) – Associate Professor of Pediatrics, Chief of Hematologic Malignancies Program, Joshua Kahan Endowed Chair in Pediatric Leukemia Research, Perelman School of Medicine, University of Pennsylvania, Division of Oncology, and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia
Saro Armenian (USA) – Director of the Division of Outcomes Research, Director of the Center for Survivorship and Outcomes, Hematologic Malignancies Institute, and Barron Hilton Chair and Professor of Pediatrics, Department of Pediatrics at City of Hope
Sean Lybrand (Switzerland) – Executive Director, Access to Healthcare, Amgen
Sendurai Mani (USA) – Associate Director for Translational Oncology, Legorreta Cancer Center, Dean’s Chair of Translational Oncology, Director, Translational Research Disease Groups, Director, Stem Cell Center, Professor of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University
Shikha Jain (USA) – Associate Professor of Medicine, Division of Hematology and Oncology, Director of Communication Strategies in Medicine at the University of Illinois Chicago, GI Oncology Integrated Practice Unit (IPU) Lead, Founder and Board Chair Women in Medicine, Founder & Chair Women in Medicine Summit, Co-Founder of IMPACT
Solange Peters (USA) – Chair of Medical Oncology, Director of the Oncology Department at CHUV Lausanne University Hospital, Former ESMO President, President of the Swiss Cancer League, Vice-President of the Swiss Academy of Multidisciplinary Oncology
Elen Baloyan (Armenia) – Managing Editor of OncoDaily, Medical Oncologist
Stephen Nimer (USA) – Director, Sylvester Comprehensive Cancer Center, Executive Dean for Research at the Miller School
Sujuan Ba (USA) – President and CEO at National Foundation for Cancer Research and the Asian Fund for Cancer Research, Co-founder of the Global Coalition for Adaptive Research and the AIM-HI Accelerator Fund
Suresh S. Ramalingam (USA) – Executive Director of Winship Cancer Institute of Emory University
Susannah Stanway (UK) – Honorary Consultant Medical Oncology at Royal Marsden NHS Foundation Trust, Senior teaching fellow at Institute of Cancer Research, Co-convenor of London Global Cancer Week
Sushmita Sen (Switzerland) – Global Medical Scientific Alliances of Oncology and Hematology of Roche
Tezer Kutluk (Turkey) – Past-President of UICC, Professor of Pediatrics and Pediatric Oncology, Chairman of the Scientific Committee at Medicana Health International
Toufic Kachaamy (USA) – Chief of Medicine and Director of Gastroenterology and Endoscopy, City of Hope, Phoenix
Tsetsegsaikhan Batmunkh (Mongolia) – CEO and Founder, National Cancer Council of Mongolia, Director of the Public Health Department at the Ministry of Health of Mongolia
Ulrika Årehed Kågström (Sweden) – President of the Union for International Cancer Control (UICC) and Secretary General of Cancerfonden
Uta Schmidt-Straßburger (Germany) – Scientific Director of the Advanced Oncology study program, Ulm University
Vania Wisdom (UK) – Senior Executive Editor and Oncology Ambassador at The Lancet
Verna Vanderpuye (Ghana) – Professor and Senior Consultant, National Center for Radiotherapy, Oncology and Nuclear Medicine, Korlebu Teaching Hospital, Accra, Co-chair of the Lancet Commission on Women and Cancer
Vinod Balachandran (USA) – Associate Attending Physician at MSK, Director of the Olayan Center for Cancer Vaccines, Yvonne Award 2024 Recipient
Vivek Subbiah (USA) – Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, Yvonne Award 2024 Recipient
Wade Swenson (USA) – Medical Director at Lakewood Health System in Staples, Minnesota, Clinical Associate Professor at the University of North Dakota School of Medicine, President-Elect of the Minnesota Chapter of the American College of Healthcare Executives, Presidential Leadership Scholar and a National Rural Health Association Rural Health Fellow, founder of the Rural Cancer Institute
Wafik El-Deiry (USA) – Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University
Yacoub Yousef (Jordan) – Consultant Ophthalmologist at the King Hussein Cancer Center
Yousef Zakharia (USA) – Professor of Medicine, Chair, Genitourinary Malignancy Disease Group, Mayo Clinic Comprehensive Cancer Center (Mayo Clinic Enterprise), Leader, Experimental Therapeutics and Phase I Clinics, Mayo Clinic Arizona
Yüksel Ürün (Turkey) – Professor of Medical Oncology, Ankara University School of Medicine, Founder of the Turkish Oncology Group Kidney Cancer Consortium (TKCC)
Zeena Salman (USA) – Lead of Gaza Medical Evacuations, Global Pediatric Medicine at St. Jude Children’s Research Hospital, recognized among The 100 Most Influential People in Oncology in 2025